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Is this septic shock? A rare case of distributive shock
CASE REPORT
INTRODUCTION
Systemic capillary leak syndrome (SCLK), also known as Clarkson’s disease, 
was first described in 1960.(1) The authors described the case of a patient with 
recurrent episodes of distributive shock and generalized edema, resulting 
from the passage of fluid and proteins from the intravascular space into the 
extravascular space.(1)
Few reports are available in the literature, with an approximate total of 150 
published cases.(2,3) SCLK may be fatal in extreme situations, when there is no 
treatment or measures to reverse shock.
The pathophysiology of this syndrome is associated with vascular endothelial 
dysfunction, allowing the passage of fluids and macromolecules from the 
vascular space into the interstitium.(4) That alteration results in the depletion of 
fluid and therefore in a state of tissue hypoperfusion and hypoxia characteristic 
of shock. Cellular elements remain in the vascular territory, resulting in elevated 
leukocyte, erythrocyte, and platelet counts.(4)
CASE REPORT
A 53-year-old Caucasian woman with a history of hypercholesterolemia, 
tobacco smoking, and degenerative spinal disease, treated with clopidogrel, 
rosuvastatin, and ethyl loflazepate began to develop symptoms of asthenia and 
generalized edema (feet, forearms, and face) five months before admission. 
Hypothyroidism was diagnosed following observation and brief analytical 
assessment (8.67µg/mL thyroid stimulating hormone - TSH, 0.20-4.20µg/mL 
reference values - RV), which improved with levothyroxine. A new episode of 
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The authors report a rare case of shock 
in a patient without significant clinical 
history, admitted to the intensive care unit 
for suspected septic shock. The patient 
was initially treated with fluid therapy 
without improvement. A hypothesis of 
systemic capillary leak syndrome was 
postulated following the confirmation of 
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severe hypoalbuminemia, hypotension, 
and hemoconcentration - a combination 
of three symptoms typical of the disease. 
The authors discussed the differential 
diagnosis and also conducted a review of 
the diagnosis and treatment of the disease.
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sudden generalized edema, which culminated in syncope, 
occurred three months later, with subsequent recovery. She 
was observed at the Emergency Room (ER) at that time, 
wherein she received complementary diagnostic tests. The 
following results were observed: 16.5g/dL hemoglobin (Hg), 
16.500U/L leukocytosis, 0.21mg/dL C-reactive protein 
(CRP; RV<0.30mg/dL), renal failure with 1.6mg/dL 
creatinine (Cr), and leukocyturia (Table 1). The patient 
was treated with ciprofloxacin and reassessed at a later 
consultation, wherein normalization of blood count and of 
renal function and protein electrophoresis with monoclonal 
peak in the gamma-globulin region were observed.
A new episode of generalized edema, profuse sweating, 
and malaise, followed by syncope, occurred on the day 
of admission. The ER assessment showed unmeasurable 
blood pressure, preserved consciousness, no response 
to fluid therapy (3,000ml of crystalloid administered), 
and oligo-anuria. The laboratory tests showed 
hemoconcentration (Table 1) (20.7g/dL Hb, 62.4% 
hematocrit - Htc and 25.400 leukocyte count) and acute 
renal failure (1.56mg/dL Cr) with metabolic acidemia 
(50% FiO2 blood gas analysis: 7.33 pH; 22.2 partial 
pressure of carbon dioxide - pCO2; 130.3 partial pressure 
of oxygen - pO2; 11.5 bicarbonate - HCO3; 2.55 lactate; 
and 20 anion gap). The electrocardiogram was negative 
for acute myocardial ischemia. The patient underwent 
thoracic-abdominal-pelvic computed tomography with 
contrast, which excluded aortic dissection, and she was 
transferred to the intensive care unit (ICU).
The patient was anxious, sweaty, and with cold extremities 
at ICU admission. She was also afebrile and had unmeasurable 
blood pressure, sinus tachycardia, and 98% oxygen saturation 
with 50% Venturi mask. The cardiopulmonary auscultation 
was normal, the abdomen was free from tenderness on 
pressure, and the lower extremities showed no edema. Central 
venous pressure was 1cmH2O. The serum albumin level was 
0.9g/dL (3.6 to 5.5g/dL RV) with 2.73g/dL total proteins 
(6.6 to 8.3g/dL RV).
Given the severe hypoalbuminemia, blood pressure, and 
diuresis (70cc urine output in 10 hours) unresponsiveness 
to fluid resuscitation with crystalloids and worsening 
of metabolic acidosis, 20% albumin replenishment and 
dialysis were started, reaching hemodynamic stability 
and fluid and electrolyte balance. The transthoracic 
echocardiogram showed a hyperdynamic left ventricular 
function with no further alterations.
The onset of severe lower limb edema, pain in the calf 
muscle region, and questionable foot pulses by palpation 
occurred three hours after admission and fluid therapy with 
crystalloids. The hypothesis of compartment syndrome 
was postulated and assessed by vascular surgery and plastic 
surgery, and the need for decompression fasciotomy 
was ruled out after performing Doppler ultrasound. 
Rhabdomyolysis with a creatine kinase peak of 8406U/L 
was observed in the laboratory tests. Clinical improvement 
with progressive decrease of leg perimeter and return of 
palpable pulses occurred 24 hours later.
On the 2nd day of hospitalization, the patient was 
orotracheally intubated due to respiratory exhaustion 
associated with fluid overload and was mechanically 
ventilated for 48 hours. On the 3rd day of hospitalization, 
diuresis resumed with spontaneous negativation of water 
balance and gradual reduction of peripheral edema, and 
dialysis was suspended on the 4th day. Hemoglobin levels 
were normalized in the first hours of fluid therapy with 
progressive normalization of serum albumin levels.
Table 1 - Progression of analytical parameters during hospitalization
1st syncope Admission to the ER 12 hours later Day 1 Day 2 Day 3 Day 5 Day 12 Hospital discharge
Hemoglobin (g/dL) 16.5 20.7 18.1 15.4 12 8.2 7.8 9.1 9.8
Hematocrit (%) 48.1 62.4 54.4 47 35.8 23.7 23.0 27.5 30.3
Leukocytes x 109/L 16.50 25.40 33.30 43.80 25.80 10.50 11.70 16.00 10.50
Urea (mg/dL) 59 54 45 32 22 85 53 67
Creatinine (mg/dL) 1.60 1.54 1.25 1.27 1.2 0.89 1.75 1.01 0.99
Potassium (mEq/dL) 4.6 4.6 4.3 3.6 3.5 3.6 3.9 3.7 4.1
Calcium (mg/dL) 5.5 7.4 8.7
Total Proteins (g/dL) 2.73 3.72 4.03
Albumin (g/dL) 0.9 2.5 3.2 3.6
Creatine phosphokinase (U/L) 87 129 2.658 8.406 6.412 3.176 355
Myoglobin 130 >4.026 >4.026 3.080 404.3 39.9
ER - Emergency Room.
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Treatment with aminophylline was started upon 
suspected SCLK diagnosis. The patient was transferred to 
the internal medicine ward on the 8th day of hospitalization.
The following results were obtained in the study and 
etiological assessment: normal prothrombin and activated 
partial thromboplastin times, transaminases, normal gamma 
glutamyl transferase, and alkaline phosphatase levels, 
8mg/dL corrected calcium, 3.8mg/dL CRP (RV<5.0). Urine 
II with 50mg/dL proteinuria and 1.56g total 24-hour urine 
protein, 50.3KUI/L total IgE (RV 0 to 100KUI/L), 2mm/h 
sedimentation rate, sterile blood cultures (two) and urine 
culture, and normal thyroid function and serum cortisol 
levels; negative viral serology (human immunodeficiency 
virus (HIV) 1/2, hepatitis B and C).
Analysis through gel electrophoresis of proteins and 
assessment of the levels of immunoglobulins was performed 
for immunological analysis. Decreased IgG and IGA levels 
were observed, with 0.79 kappa/lambda free light chains 
ratio (1.4 to 2.7 RV), and immunofixation showed IgG 
lambda-type monoclonal component and high serum 
levels, 185.0mg/L (5.71 to 26.30 RV). The 24-hour urinary 
excretion showed a significant increase in lambda light chains 
(133.0mg/L; RV<4.0) and Bence Jones protein positive for 
lambda free light chains. It should be noted that protein 
electrophoresis performed during the leak phase showed 
no monoclonal bands (Figure 1), although the replicate, 
after solving the acute episode, showed previously reported 
gammopathy (Figure 2). The patient was subjected to bone 
biopsy with description of interstitial and perivascular plasma 
cells, without cytologic atypia, monotypic for lambda-chains, 
which accounted for 5% of the medullary population.
Figure 1 - Protein electrophoresis in the acute phase, showing no alterations 
regarding the gamma-globulin region.
Figure 2 - Protein electrophoresis performed during hospitalization following 
the stabilization of an acute episode, showing alterations regarding the 
gamma-globulin region.
The patient was discharged on the 20th day of 
hospitalization without peripheral edema, with normal 
renal function, 3.6g/dL albumin, normal thyroid function 
without levothyroxine, and maintaining treatment with 
aminophylline. The patient was referred to a hematology 
and internal medicine consultation.
The patient returned to the hospital one month after 
discharge, reporting blood pressure values lower than the 
usual pattern. However, hypotension was not detected 
during the medical observation. The patient showed 
swelling of the face and was admitted to the intermediate 
care unit of the internal medicine department. Laboratory 
tests showed normal albumin on admission (3.9g/L), 
which decreased to 3.36g/L 24 hours later. Accordingly, 
immunoglobulin therapy was started, with regression 
of clinical symptoms. The patient has maintained the 
monthly treatment with 2g/kg immunoglobulin for 2 
days, without relapse of the disease since then.
DISCUSSION
Several diagnoses may mimic SCLK, and the frequent 
causes of rapidly progressing shock must first be excluded.
The elements to be considered in the differential 
diagnosis of shock, contextualized with this clinical case, are 
as follows: severe hypoalbuminemia, hemoconcentration, 
and development of edema without evidence of fluid 
overload. That triad is not characteristic of cardiogenic, 
septic, or anaphylactic shock or angioedema, and cardiac 
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dysfunction is not observed on the echocardiogram, in the 
clinical case. The CRP levels were normal; the culture tests 
were sterile; there was no history of allergies, urticaria, or 
eosinophilia; and the total IgE levels were normal.
Simultaneously, we may list kidney, liver, or nutritional 
factors as the possible etiology of hypoalbuminemia.
No clinical signs of chronic liver disease were found. The 
laboratory tests showed no alterations, especially regarding 
the prothrombin time, and the abdominal computed 
tomography showed no changes in liver structure. Acute 
renal injury was observed, although the urine protein 
levels were outside the nephrotic range. There was no 
clinical history information available that would indicate 
nutritional causes for hypoalbuminemia, the patient had 
a diverse diet, and the protein electrophoresis excluded 
protein-losing enteropathy.
There are endocrine causes that relate to shock 
and fluid retention in the third space, especially 
hypothyroidism. However, the analytical parameters of 
thyroid function were normal. Generalized edema may 
also be associated with Cushing’s syndrome with secondary 
hyperaldosteronism. However, the patient showed no 
stigmata of hypercortisolism or of elevated serum cortisol.
For this clinical case, all those differential diagnoses may 
be generally excluded due to the elevated hematocrit, which 
is consistent with decreased effective circulating volume.
The pathophysiology of SCLK may be divided 
into two phases.(1,2) The first results from an increase in 
capillary permeability that favors the passage of fluid and 
albumin into the extravascular space, which is manifested 
by generalized edema, hemoconcentration, and 
hypoproteinemia. This phase is associated with distributive 
shock in the most severe cases, typically attended by 
preservation of consciousness.(5) The second phase is 
characterized by vascular repletion with hypervolemia.(1,2)
The etiology of SCLK is still poorly understood. 
However, most cases are associated with monoclonal 
gammopathy, predominantly IgG kappa.(6) Despite studies 
with mixed results, many authors advocate a direct action 
of IgG paraprotein, with subsequent endothelial injury and 
capillary hyperpermeability.(5)
The formation of edema may result from an alteration 
in the function of endothelial cells induced by cytokines(7) 
because cases associated with interleukin-2 therapy used 
in the treatment of disseminated renal cell carcinoma 
and melanoma(8) and with interferon beta used in the 
treatment of multiple sclerosis(9,10) have been reported.
Given the rarity of this situation, the data available in 
the literature are scarce and refer only to case series and a 
few observational studies.
The treatment of the acute phase of SCLK is empirical 
and based on supportive therapy, wherein cautious fluid 
resuscitation is preferred,(5) given the risk of compartment 
syndrome and respiratory failure due to acute pulmonary 
edema during the repletion phase resulting from initial 
aggressive fluid resuscitation.(5) The next phase consists 
of aminergic support organ therapy with dialysis and 
ventilatory support when needed.
The existence of any clinical benefit from replenishing 
a severe deficit of albumin is questionable because 
the administered albumin may be diverted into the 
interstitial space due to alterations in the capillary 
barrier.(6) However, the initial treatment during the acute 
phase of SCLK with crystalloid administration may 
not suffice to maintain adequate intravascular volume 
status.(6) Thus, the potential clinical benefits of a trial 
of volume expansion with albumin as hemodynamic 
stabilizer and intravascular oncotic pressure regulator for 
rescue therapy should be assessed.
SCLK is a potentially relapsing disease. The relapses 
can have different degrees of severity, and each of them 
may be eventually fatal, leading to particular interest in 
treatment to prevent recurrences.
Treatment with beta-2 agonists, including 
terbutaline, and with xanthines, including theophylline 
and aminophylline, reduces SCLK relapse. A possible 
explanation is the decreased capillary permeability induced 
by histamine and bradykinin,(11) and the inhibition of 
apoptosis of endothelial cells resulting from the increased 
intracellular cAMP.(5) Based on studies with promising 
results, some authors recommend the empirical use of 
monthly immunoglobulins (2g/kg) for relapse prevention 
in refractory cases.(5,12)
In our specific case, a controlled initial fluid resuscitation 
had to be performed, given the risk of pulmonary and 
soft tissue edema with subsequent development of 
compartment syndrome. Albumin was administered to 
preserve the intravascular oncotic pressure, given the severe 
hypoalbuminemia and refractoriness to fluid resuscitation 
with crystalloids. Despite subsequent progression to acute 
pulmonary edema and severe lower limb edema, clinical 
stability was reached after 48 hours.
Aminophylline was initially administered due to the 
triad typical of SCLK with relapsing symptoms; however, 
relapse of the syndrome occurred under this treatment. 
Therefore, it was decided to begin immunoglobulin 
therapy. No new episodes of relapse occurred for 22 
months following the introduction of this experimental 
therapy. It should be noted that the diagnosis of 
monoclonal gammopathy, which strengthens the diagnosis 
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of SCLK, could have been overlooked during the SCLK 
phase, wherein no evidence of M band was found in 
the electrophoresis, most likely because of protein losses 
through urine.
CONCLUSION
Strong clinical suspicion, confirmation of 
hemoconcentration with paradoxical hypoalbuminemia, 
and exclusion of other causes of shock associated with 
generalized edema are necessary to diagnose systemic 
capillary leak syndrome.
The clinical case is paradigmatic of frequent disease 
relapse episodes, and the 3rd relapse is a serious and 
potentially fatal complication. No new relapses have been 
observed thus far with the monthly immunoglobulin 
regimen.
The progression of systemic capillary leak syndrome 
may be lethal at an early phase of vascular leakage due 
to distributive shock, and death may occur due to 
pulmonary edema at a later stage of vascular repletion with 
hypervolemia. Knowledge of this syndrome is important 
to prevent treatment that worsens the prognosis.
Os autores apresentam um caso raro de choque em doente 
sem antecedentes pessoais significativos, admitido na unidade de 
terapia intensiva por suspeita de choque séptico. Inicialmente, 
foi tratado com fluidoterapia sem melhoria, tendo sido aventada 
a hipótese de síndrome de hiperpermeabilidade capilar, após 
confirmação de hipoalbulinemia paradoxal grave, hipotensão e 
hemoconcentração exuberante - tríade característica da doença. 
Os autores discutiram o diagnóstico diferencial e ainda realizaram 
uma revisão do diagnóstico e do tratamento da doença.
RESUMO
Descritores: Permeabilidade capilar; Hipotensão; Choque 
séptico; Hemoconcentração; Edema; Relatos de casos
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